Yakira Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Yakira Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,981	Closed	-$1.89M	–	342
2023 Q4	$1.89M	Buy	+5,981	New	+$1.16M	0.62%	54

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Yakira Capital Management's KRTX Position: Q1 2024 in Review

Yakira Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5,981 shares — an estimated $1.89M sold.

Yakira Capital Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.89M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Yakira Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Yakira Capital Management sold 5,981 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.89M.
Yakira Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Yakira Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.89M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Yakira Capital Management's 13F filing for Q1 2024, filed 14 May 2024.